Clinical Trials Directory

Trials / Completed

CompletedNCT05701878

COVID-19 Self-testing Study

Field Test of COVID-19 Self-testing With Rapid Antigen Tests

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.

Detailed description

Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management. The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSMARTest mobile app for COVID-19 self-testingThe mobile app has self-testing features and information with regard to self-testing and COVID-19.

Timeline

Start date
2023-04-03
Primary completion
2023-09-06
Completion
2023-09-06
First posted
2023-01-27
Last updated
2024-02-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05701878. Inclusion in this directory is not an endorsement.